PGX-CYP2C19 StripAssay®
CYP2C19 Pharmacogenomic Genotyping
The PGX-CYP2C19 StripAssay® is a simple and cost-effective kit for identifying genetic variations in the CYP2C19 gene that alter drug and metabolite concentrations, potentially causing toxicity, adverse reactions, or reduced efficacy.
Key Features
CYP2C19 Variant Detection
Identifies genetic variations in the CYP2C19 gene that cause altered drug concentrations in the body.
Toxicity & Efficacy Prediction
Supports prediction of toxicity, adverse reactions, or reduced efficacy based on CYP2C19 metabolizer status.
Broad Drug Coverage
CYP2C19 metabolizes clopidogrel, PPIs, antidepressants, and many other widely prescribed drugs.
Simple & Cost Effective
Simple, cost-effective kit for routine pharmacogenomic testing in clinical research laboratories.
For Research Use Only (RUO)
PGX-CYP2C19 StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.